MCM
BBNX

MAI Capital Management’s Beta Bionics BBNX Stock Holding History

MAI Capital Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,300
Closed -$13K – 4969
2026
Q1 		$13K Buy
1,300
+675
+108% +$9.98K ﹤0.01% 3018
2025
Q4 		$19K Hold
625
– – ﹤0.01% 2539
2025
Q3 		$12.4K Hold
625
– – ﹤0.01% 2650
2025
Q2 		$9.1K Hold
625
– – ﹤0.01% 2781
2025
Q1 		$7.65K Buy
+625
New +$11.7K ﹤0.01% 2596

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

MAI Capital Management's BBNX Position: Q2 2026 in Review

MAI Capital Management sold out of Beta Bionics (BBNX) in Q2 2026, closing a stake of 1,300 shares — an estimated $13K sold.

MAI Capital Management first reported a position in BBNX in Q1 2025 and held it in 5 quarters. The position peaked at $19K in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • MAI Capital Management reported no remaining Beta Bionics position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 1,300 Beta Bionics shares in Q2 2026, an estimated $13K.
  • MAI Capital Management first reported a position in Beta Bionics in Q1 2025 and held it in 5 quarters.
  • MAI Capital Management's Beta Bionics position peaked at $19K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.